Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
1.380
-0.070 (-4.83%)
Oct 17, 2025, 4:00 PM EDT - Market closed
Skye Bioscience Market Cap
Skye Bioscience has a market cap or net worth of $42.76 million as of October 17, 2025. Its market cap has decreased by -60.51% in one year.
Market Cap
42.76M
Enterprise Value
-5.45M
1-Year Change
-60.51%
Ranking
Category
Stock Price
$1.38
Market Cap Chart
Since April 11, 2024, Skye Bioscience's market cap has decreased from $356.10M to $42.76M, a decrease of -87.99%. That is a compound annual growth rate of -75.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 42.80M | -50.17% |
| Dec 31, 2024 | 85.90M | -75.88% |
| Apr 11, 2024 | 356.10M | - |
View and export this data all the way back to 2024. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.59B |
| Johnson & Johnson | 462.69B |
| AbbVie | 400.78B |
| UnitedHealth Group | 323.03B |
| AstraZeneca | 261.44B |
| Novo Nordisk | 254.14B |
| Novartis AG | 253.93B |
| Abbott Laboratories | 222.13B |